HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

J Michael Dixon Selected Research

letrozole (Femara)

7/2015Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer.
10/2014Molecular changes in lobular breast cancers in response to endocrine therapy.
1/2013PIK3CA genotype and a PIK3CA mutation-related gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancer.
8/2012Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer.
12/2011Invasive lobular carcinoma: response to neoadjuvant letrozole therapy.
12/2011Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.
2/2011Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability.
2/2010A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer.
8/2009Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.
6/2009Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


J Michael Dixon Research Topics

Disease

49Breast Neoplasms (Breast Cancer)
12/2015 - 03/2002
38Neoplasms (Cancer)
12/2015 - 01/2002
3Neoplasm Metastasis (Metastasis)
09/2015 - 05/2006
2Carcinoma (Carcinomatosis)
09/2015 - 10/2014
2Lobular Carcinoma
10/2014 - 12/2011
2Noninfiltrating Intraductal Carcinoma (DCIS)
03/2010 - 08/2007
1Anoxia (Hypoxia)
09/2015
1Thymoma (Thymic Carcinoma)
01/2015
1Ductal Carcinoma
10/2014
1Pain (Aches)
08/2013
1Nausea
08/2013
1Asthenia
08/2013
1Bone Resorption
02/2010
1Stroke (Strokes)
12/2006
1Endometrial Neoplasms (Endometrial Cancer)
12/2006
1Ovarian Neoplasms (Ovarian Cancer)
01/2005
1Infertility (Sterility)
01/2002

Drug/Important Bio-Agent (IBA)

28Estrogens (Estrogen)FDA Link
12/2015 - 01/2002
23TamoxifenFDA LinkGeneric
01/2012 - 01/2002
21letrozole (Femara)FDA LinkGeneric
07/2015 - 06/2002
18Aromatase InhibitorsIBA
12/2015 - 06/2002
14anastrozole (Arimidex)FDA LinkGeneric
01/2013 - 06/2002
12HormonesIBA
03/2015 - 01/2002
8Aromatase (CYP19)IBA
03/2010 - 06/2002
5Biological Markers (Surrogate Marker)IBA
01/2015 - 01/2004
5exemestane (Aromasin)FDA Link
03/2010 - 03/2002
4everolimusFDA Link
01/2013 - 06/2009
4DNA (Deoxyribonucleic Acid)IBA
01/2012 - 07/2008
3Progesterone Receptors (Progesterone Receptor)IBA
12/2015 - 04/2005
3Estradiol (Estrace)FDA LinkGeneric
08/2012 - 04/2008
2Estrogen Receptor alphaIBA
07/2015 - 12/2006
2RNA (Ribonucleic Acid)IBA
12/2011 - 02/2008
2Phosphotransferases (Kinase)IBA
01/2011 - 04/2010
2Proteins (Proteins, Gene)IBA
01/2010 - 08/2009
2Estrone (Folliculin)FDA Link
01/2010 - 04/2008
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
02/2009 - 01/2002
2Epidermal Growth Factor Receptor (EGF Receptor)IBA
07/2006 - 08/2005
1Estrogen Receptor Modulators (Antiestrogen)IBA
12/2015
1sulfamic acid (ammonium sulfamate)IBA
09/2015
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
09/2015
1Cadherins (E-Cadherin)IBA
10/2014
1Messenger RNA (mRNA)IBA
05/2014
1CreatinineIBA
08/2013
1AZD 2281IBA
08/2013
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
08/2013
1Holliday Junction ResolvasesIBA
03/2013
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2013
1fulvestrant (Faslodex)FDA Link
01/2013
1estrone sulfate (Evex)FDA Link
08/2012
1CollagenIBA
01/2012
1Eukaryotic Initiation Factor-4EIBA
01/2011
1Phenobarbital (Luminal)FDA Link
01/2011
1Sirolimus (Rapamycin)FDA Link
01/2011
1celecoxib (Celebrex)FDA Link
03/2010
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2010
1Surface Antigens (Surface Antigen)IBA
08/2009
1docetaxel (Taxotere)FDA Link
08/2009
1Ribosomal Proteins (Ribosomal Protein)IBA
03/2009
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
07/2008
1Ki-67 Antigen (Ki 67 Antigen)IBA
01/2007
1Selective Estrogen Receptor Modulators (SERM)IBA
12/2006
1Peptide Elongation Factors (Elongation Factor)IBA
01/2005

Therapy/Procedure

14Neoadjuvant Therapy
09/2015 - 03/2002
8Drug Therapy (Chemotherapy)
09/2015 - 01/2002
6Segmental Mastectomy (Lumpectomy)
03/2015 - 01/2004
5Radiotherapy
03/2015 - 05/2006
4Mastectomy (Mammectomy)
01/2009 - 01/2004
3Adjuvant Chemotherapy
05/2010 - 08/2008
2Heterologous Transplantation (Xenotransplantation)
09/2015 - 12/2006
2Therapeutics
01/2012 - 01/2011
1Immunotherapy
12/2015
1Aftercare (After-Treatment)
09/2015
1Mammaplasty (Breast Reconstruction)
09/2012
1Palliative Care (Palliative Medicine)
06/2002